Vaxart VXRT
OTC VXRT
$0.44 -0.04 (-8.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Vaxart (VXRT) Income from Discontinued Operations (2011 - 2012)

Updated

Vaxart's Income from Discontinued Operations was $991,000 in FY2012.

Analysis

Vaxart (VXRT) Income from Discontinued Operations (2011 - 2012) Analysis & Trends

  • Per Business Quant data, Income from Discontinued Operations in earlier years was $2.98 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,147.74 Bn 1,116.33 Bn 19.71 Bn -
2 Johnson & Johnson 636.22 Bn 556.08 Bn 17.30 Bn -
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -
4 Merck 357.93 Bn 312.30 Bn 12.21 Bn -
5 Novartis Ag 301.67 Bn 265.66 Bn 11.24 Bn -
6 Astrazeneca 264.02 Bn 237.70 Bn 12.86 Bn -
7 Amgen 239.31 Bn 194.70 Bn 7.24 Bn -
8 Gilead Sciences 194.97 Bn 169.17 Bn 6.22 Bn -
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 8.00 Mn
10 Vaxart 108.73 Mn 44.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 991,000.00
Sep 24, 2011 2.98 Mn
API Access

Vaxart Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=VXRT&period=max&api_key=YOUR_API_KEY